Organon & Co. (OGN)
(Delayed Data from NYSE)
$19.03 USD
-0.63 (-3.20%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $19.03 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth B Momentum B VGM
Balance Sheet
Fiscal Year End for Organon & Co falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 693 | 706 | 737 | 70 | 319 |
Receivables | 1,744 | 1,475 | 1,382 | 1,360 | 1,474 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 1,315 | 1,003 | 915 | 971 | 1,071 |
Other Current Assets | 756 | 747 | 726 | 977 | 1,091 |
Total Current Assets | 4,508 | 3,931 | 3,760 | 3,378 | 3,955 |
Net Property & Equipment | 1,183 | 1,018 | 973 | 998 | 680 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 5,136 | 5,252 | 5,254 | 5,106 | 5,172 |
Deposits & Other Assets | 1,231 | 754 | 694 | 438 | 741 |
Total Assets | 12,058 | 10,955 | 10,681 | 9,920 | 10,548 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1,314 | 1,132 | 1,382 | 294 | 258 |
Current Portion Long-Term Debt | 9 | 8 | 9 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 1,389 | 1,188 | 1,021 | 752 | 807 |
Income Taxes Payable | 206 | 184 | 185 | 288 | 242 |
Other Current Liabilities | 0 | 0 | 0 | 1,150 | 34 |
Total Current Liabilities | 2,918 | 2,512 | 2,597 | 2,484 | 1,341 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 47 | 19 | 4 | 128 | 139 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 8,751 | 8,905 | 9,125 | 0 | 70 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 412 | 411 | 463 | 1,822 | 1,963 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 12,128 | 11,847 | 12,189 | 4,434 | 3,513 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 3 | 3 | 3 | 0 | 0 |
Capital Surplus | 25 | 0 | 0 | 0 | 0 |
Retained Earnings | 443 | -331 | -998 | 0 | 0 |
Other Equity | -541 | -564 | -513 | 5,486 | 7,035 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | -70 | -892 | -1,508 | 5,486 | 7,035 |
Total Liabilities & Shareholder's Equity | 12,058 | 10,955 | 10,681 | 9,920 | 10,548 |
Total Common Equity | -70 | -892 | -1,508 | 5,486 | 7,035 |
Shares Outstanding | 255.60 | 254.30 | 253.50 | NA | NA |
Book Value Per Share | -0.27 | -3.51 | -5.95 | -0.05 | -0.07 |
Fiscal Year End for Organon & Co falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 704 | 575 | 693 | 414 | 326 |
Receivables | 1,617 | 1,547 | 1,744 | 1,648 | 1,672 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 1,287 | 1,263 | 1,315 | 1,186 | 1,199 |
Other Current Assets | 901 | 811 | 756 | 802 | 761 |
Total Current Assets | 4,509 | 4,196 | 4,508 | 4,050 | 3,958 |
Net Property & Equipment | 1,162 | 1,180 | 1,183 | 1,096 | 1,110 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 5,287 | 5,321 | 5,136 | 5,164 | 5,195 |
Deposits & Other Assets | 1,196 | 1,194 | 1,231 | 702 | 716 |
Total Assets | 12,154 | 11,891 | 12,058 | 11,012 | 10,979 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1,243 | 955 | 1,314 | 1,067 | 1,115 |
Current Portion Long-Term Debt | 9 | 9 | 9 | 8 | 8 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 1,302 | 1,385 | 1,389 | 1,255 | 1,101 |
Income Taxes Payable | 201 | 196 | 206 | 161 | 163 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 2,755 | 2,545 | 2,918 | 2,491 | 2,387 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 60 | 44 | 47 | 43 | 32 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 8,647 | 8,705 | 8,751 | 8,646 | 8,722 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 548 | 412 | 421 | 393 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 12,010 | 11,843 | 12,128 | 11,601 | 11,534 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 3 | 3 | 3 | 3 | 3 |
Capital Surplus | 63 | 49 | 25 | 0 | 0 |
Retained Earnings | 690 | 573 | 443 | -16 | -25 |
Other Equity | -612 | -577 | -541 | -576 | -533 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 144 | 48 | -70 | -589 | -555 |
Total Liabilities & Shareholder's Equity | 12,154 | 11,891 | 12,058 | 11,012 | 10,979 |
Total Common Equity | 144 | 48 | -70 | -589 | -555 |
Shares Outstanding | 257.40 | 257.10 | 255.60 | 255.60 | 255.00 |
Book Value Per Share | 0.56 | 0.19 | -0.27 | -2.30 | -2.18 |